EurekAlert! -
24 May 2021 06:00
(Medical University of South Carolina) Hollings researchers found a modified peptide carrier that was delivering the siRNA drug by adhering to and potentially moving along cell filopodia, leading to more efficient cell entry and improved gene silencing.
Share this Article